Hyperlipidemias Clinical Trial
Official title:
Effects of Omega-3 Polyenoic Acid on Blood Lipid, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia
Patients with hyperlipidemia will be allocated into intervention or control group randomly. Participants of intervention group will be provided with Omega-3 PUFA, while participants of control group will be provided with placebo which looked same as the drug of intervention group. During the study, all participants can have nutritional counseling and education for low-fat diet. The lipids, inflammatory factors, weight, and body composition will be assessed and recorded before, at the middle, and end of the study.
Randomization tables were generated by the statistician and provided to the investigational pharmacist who distributed the blinded pills to participants. Participants of intervention group will be provided with Omega-3 PUFA, while participants of control group will be provided with placebo which looked same as the drug of intervention group. During the study, all participants can have nutritional counseling and education for low-fat diet. The lipids, inflammatory factors, weight, and body composition will be assessed and recorded before, at the middle, and end of the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03793985 -
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
|
Phase 1 | |
| Recruiting |
NCT03947866 -
Ezetimibe-Rosuvastatin Evaluation Study
|
||
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Completed |
NCT04516291 -
A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
|
Phase 2 | |
| Completed |
NCT04701775 -
Effect of Different Probiotic Strains in Hypercholesterolemic Patients
|
N/A | |
| Completed |
NCT03632668 -
Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072
|
Phase 1 | |
| Completed |
NCT03534661 -
L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
|
Phase 2/Phase 3 | |
| Completed |
NCT03422666 -
Plasma Lipoprotein Response to Glucagon-like Peptide-2
|
Phase 2/Phase 3 | |
| Completed |
NCT00536796 -
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
|
N/A | |
| Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
| Recruiting |
NCT04560296 -
Community-based E-Health Program for Older Adults Living With Chronic Diseases
|
N/A | |
| Terminated |
NCT04073134 -
The CHORAL Flow Study
|
Phase 4 | |
| Recruiting |
NCT05103254 -
Bempedoic Acid Pregnancy Surveillance Program
|
||
| Active, not recruiting |
NCT05082350 -
Nutritional Intervention With Black Garlic
|
N/A | |
| Not yet recruiting |
NCT04398771 -
To Evaluate Safety and Effectiveness of RovatitanTab.
|
||
| Not yet recruiting |
NCT04064281 -
The Healthy Cantonese Diet on Cardiometabolic Syndrome
|
N/A | |
| Recruiting |
NCT06257641 -
Impact of the Mediterranean Diet on Patients With Psoriasis
|
N/A | |
| Completed |
NCT03690778 -
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
|
Phase 1 | |
| Completed |
NCT04354987 -
Compare the Pharmacokinetics and Safety of CKD-391
|
Phase 1 | |
| Completed |
NCT03337308 -
A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
|
Phase 3 |